Scientific Advisory Committee

The Scientific Advisory Committee (SAC)

The Scientific Advisory Committee is an advisory committee to the MAC. The SAC assists investigators in the development of new study proposals, oversees ongoing studies and advises the MAC on scientific matters that may arise.

If you would like to be involved in the ALTG Scientific Advisory Committee or a sub-group committee, please contact us so we can discuss this further.

Members and roles

Chris Brown – Data Centre Representative, Statistics

Chris Brown has been a Biostatistician with the NHMRC Clinical Trials Centre since 2005 and worked with the ALTG since 2008. He has an undergraduate degree in Statistics from the University of Sydney and a Masters in Biostatistics from the Biostatistics Collaboration of Australia. He has a record of accomplishment in research grants and trials-related publications, has experience designing studies and in teaching statistics at the postgraduate level and to oncology specialists.

Fraser Brims – Working group Co-Chair, Early NSCLC

A/Prof Fraser Brims is a Consultant Respiratory Physician at Sir Charles Gairdner Hospital and Director of Early Years Communication and Clinical Skills at Curtin University Medical School, based in Perth, Western Australia (WA). A/Prof Brims has clinical and research interests in early lung cancer detection and he leads the WA Asbestos Review Program, a prospective longitudinal cohort of ~1,750 individuals with annual low dose CT scans for the detection of early lung cancer.

Michael Harden – Working group Co-Chair, Early NSCLC

Prior to becoming a Cardiothoracic Surgeon Dr Harden worked as a Chemical Engineer and later completed a Masters Degree in Biomedical Engineering, majoring in Cardiovascular Fluid Dynamics and Physiological Fluid Mechanics. He obtained his fellowship of The Royal Australasian College of Surgeons in Cardiothoracic Surgery and completed an advanced CardioThoracic Fellowship, gaining specialist training in Video Assisted Thoracic Surgery (VATS), including VATS Lobectomies at Royal Melbourne Hospital in 2012. Dr Harden has a special interest in minimally invasive thoracic oncology. In addition, he is also trained in adult cardiac surgery. Dr Harden practises at the North Shore Hospital campus. He currently has rooms at North Sydney and at Gosford Private Medical Centre.

Ken O’Byrne – Working group Co-Chair, Advanced NSCLC

Prof O’Byrne is a Consultant and Professor in Medical Oncology at the Princess Alexandra Hospital and the Queensland University of Technology. He has conducted translational ‘bench-to-bedside-and back-again’ research over the past 25 years with a focus on solid epithelial tumours, in particular in thoracic malignancies.  He is involved in the International Association for the Study of Lung Cancer (IASLC) and Thoracic Alliance for Cancer Trials (TACT) and a member of Medical Oncology Group of Australasia (MOGA) and Australian Genomics Health Alliance (AGHA).

Anita McGrath – Consumer Representative

Anita McGrath is a Consumer Representative on a number of working groups in both not for profit organisations and Queensland Health. This includes Cancer Care Services and Hearth & Lung clinical stream working groups within Metro North Hospital Health Service (Qld Health). She also works with organisations such as Lung Foundation Australia and Rare Cancers Australia. Anita started consumer representative work after being diagnosed with NSCLC lung cancer in 2014. Prior to her cancer diagnosis she worked as an accountant in the travel industry.